NCT00033111View on ClinicalTrials.gov

A Study of Cabergoline for the Treatment of Cocaine Dependence - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

June 30, 2001

Study Completion Date

April 30, 2004

Conditions
Cocaine-Related DisordersSubstance-Related Disorders
Interventions
DRUG

Cabergoline

DRUG

Placebo

sugar pill manufactured to mimic cabergoline 05mg tablet

Trial Locations (2)

29425

Medical University of South Carolina, Charleston

90502

Torrance Clinic, Torrance

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00033111 - A Study of Cabergoline for the Treatment of Cocaine Dependence - 1 | Biotech Hunter | Biotech Hunter